Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia, Delivering 77% Sensitivity at Low Viral Loads
May 20, 2021 07:30 ET
|
Achiko AG
Production of First 1,000 AptameX Test Kits is Concluded in Singapore (initial capacity to test 10,000 patients per day).AptameX Delivers Sensitivity of 77% (95% CI: 75.94 - 79.24) at a High Industry...
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team
May 04, 2021 07:30 ET
|
Achiko AG
Appoints Robert Rieder as Chief Financial OfficerChief Operating Officer Chris Young to Retire Focus on Product Development, Lowering Cost Profile and Improved Alignment of Resources ZURICH,...
Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
January 25, 2021 07:30 ET
|
Achiko AG
Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...
Achiko Strengthens Leadership Team with New President and New SVP Commercialization
January 11, 2021 07:30 ET
|
Achiko AG
Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...
Achiko Partners with Udayana University for Covid-19 Testing Research in Bali, Indonesia
December 04, 2020 07:00 ET
|
Achiko AG
Achiko signed a research agreement with Udayana University’s Research Department to study the practicability of a mass testing approach with Teman Sehat and Gumnuts when availableThe Study will focus...